Huadong Medicine Co., Ltd
000963
Classifica tra le azioni
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Prezzo delle azioni
$3.89
Capitalizzazione di mercato
$6.83B
Variazione (1 giorno)
-2.22%
Variazione (1 anno)
-30.58%
Paese
CN
Scambia Huadong Medicine Co., Ltd (000963)
Categoria
Healthcare
Margine operativo per Huadong Medicine Co., Ltd (000963)
Margine operativo al October 2026 TTM: 9.26%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Huadong Medicine Co., Ltd, il margine operativo attuale (TTM) è 9.26%. Alla fine del 2024, il margine operativo era 10.32%.
Storico del margine operativo per Huadong Medicine Co., Ltd da 2001 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 9.26% | -1.70% |
| 2025 | 9.42% | -8.72% |
| 2024 | 10.32% | 21.41% |
| 2023 | 8.50% | 4.68% |
| 2022 | 8.12% | -1.69% |
| 2021 | 8.26% | -19.96% |
| 2020 | 10.32% | 7.72% |
| 2019 | 9.58% | 0.95% |
| 2018 | 9.49% | 12.84% |
| 2017 | 8.41% | 15.05% |
| 2016 | 7.31% | 14.94% |
| 2015 | 6.36% | 4.09% |
| 2014 | 6.11% | -1.61% |
| 2013 | 6.21% | -0.64% |
| 2012 | 6.25% | -1.88% |
| 2011 | 6.37% | 10.78% |
| 2010 | 5.75% | -22.72% |
| 2009 | 7.44% | 19.04% |
| 2008 | 6.25% | 0.00% |
| 2007 | 6.25% | 40.13% |
| 2006 | 4.46% | -10.62% |
| 2005 | 4.99% | 58.41% |
| 2004 | 3.15% | 1.29% |
| 2003 | 3.11% | -20.05% |
| 2002 | 3.89% | -24.32% |
| 2001 | 5.14% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 19.41% | -97.90% |
DE
|
|
| 19.68% | -97.87% |
DE
|
|
| 10.52% | -98.86% |
JP
|
|
| 17.08% | -98.16% |
CH
|
|
| 22.93% | -97.52% |
IN
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.